Efter 24 måneder sås en statistisk signifikant forskel på 12, 9% til fordel for Visudyne sammenlignet med placebo (46, 2% mod 33, 3%, p=0, 023).
At month 24, a statistically significant difference of 12.9% in favour of Visudyne compared to placebo was observed (46.2% versus 33.3%, p=0.023).